FindTrial
Sign In

Intervention for patients with peptic ulcer bleeding positive for Helicobacter pylori based on an information platform: A randomized controlled trial

Intervention for patients with peptic ulcer bleeding positive for Helicobacter pylori based on an information platform: A randomized controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500102353
Enrollment
Unknown
Registered
2025-05-13
Start date
2025-08-01
Completion date
Unknown
Last updated
2025-05-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hp-positive Peptic Ulcer Bleeding

Interventions

Intervention group:Supported by information platforms
Control group:Standard discharge guidance

Sponsors

Nanjing First Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) Diagnosed with peptic ulcer bleeding, and the carbon-13 urea breath test or rapid urease test is positive; 2) The patient agrees to use a standardized 14-day quadruple therapy (two antibiotics plus a proton pump inhibitor and a bismuth compound) to eradicate Helicobacter pylori.

Exclusion criteria

Exclusion criteria: 1) Bleeding caused by tumor rupture, esophageal or gastric varices, and other reasons; 2) Patients with a history of mental illness or altered consciousness.

Design outcomes

Primary

MeasureTime frame
Ulcer healing rate;Clinical Symptom Score;Total effective rate;Helicobacter pylori eradication rate;—

Secondary

MeasureTime frame
Knowledge level related to Helicobacter pylori;Quality of life;medication compliance;Psychological status;—

Countries

China

Contacts

Public ContactYuan Tian

Nanjing First Hospital

601821587@qq.com+86 177 1453 4569

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026